Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Delayed release coated tablet of bupropion hydrochloride

United States Patent:  6,143,327

Inventors:  Seth; Pawan (Irvine, CA)

Assignee:  Pharma Pass LLC (Irvine, CA)

Appl. No.:  459459

Filed:  December 13, 1999

Abstract

The invention provides a delayed release coated tablet, free of stabilizer and free of pore-forming agent comprising: (i) a core consisting essentially of bupropion hydrochloride, a binder and a lubricant; and (ii) a first coating consisting essentially of a water-insoluble, water-permeable film-forming polymer, a plasticizer and a water-soluble polymer; and (iii) a second coating consisting essentially of a methacrylic polymer and a plasticizer therefor.

SUMMARY OF THE INVENTION

The invention provides a delayed release coated tablet comprising:

(i) a core comprising bupropion hydrochloride and conventional excipients, free of stabilizer; and

(ii) a first coating consisting essentially of a water-insoluble, water-permeable film-forming polymer, a plasticizer and a water-soluble polymer,

(iii) a second coating consisting essentially of a methacrylic polymer and a plasticizer therefor.

The invention thus provides a new bupropion hydrochloride delayed release composition under the form of a coated tablet free of stabilizer of any kind including those with acidic pH or with antioxidant properties. Also, the delayed release is obtained thanks to a semi-permeable release coating, free of (monomeric) pore-forming agent.

The tablets of the invention exhibit specific dissolution profiles.

The invention also provides a tablet comprising the delayed release coated tablet of the invention, coated with a bupropion hydrochloride immediate release coating.

Claim 1 of 19 Claims

What is claimed is:

1. A delayed release coated tablet comprising:

(i) a core comprising bupropion hydrochloride and conventional excipients, free of stabilizer; and

(ii) a first coating consisting essentially of a water-insoluble, water-permeable film-forming polymer, a plasticizer and a water-soluble polymer; and

(iii) a second coating consisting essentially of a methacrylic polymer and a plasticizer therefor;

exhibiting a dissolution profile such that after 2 hours, from 0 up to 30% of the bupropion hydrochloride is released, after 4 hours, from 3 to 22% of the bupropion hydrochloride is released, after 6 hours, from 15 to 38% of the bupropion hydrochloride is released, after 8 hours, more than 40% of the bupropion hydrochloride is released.



____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]